Contineum Therapeutics, Inc.
$17.05
-0.20 (-1.16%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +8.3%
- 3 Months
- +26.4%
- YTD
- +49.2%
- 1 Year
- +70.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 67.5%
- Largest decline max drawdown, since Aug 2025
- -29.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.12
Own CTNM?
See how CTNM contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.